Ending Specialized Follow-Up Feasible in Asymptomatic, Low-Risk Leukemia

THURSDAY, April 18, 2024 -- For select patients with asymptomatic, lower-risk chronic lymphocytic leukemia, ending specialized follow-up (sFU) is feasible and safe, according to a study published in the March 1 issue of Blood Advances.Christian...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news